Malin Corporation | MLC - Ebitda


Malin Corporation reported EUR-1.1M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
ALKERMES USD 139.22M 58.96M Jun/2026
Avita Medical AUD -9.69M 12.21M Dec/2025
Dianthus Therapeutics USD -46.46M 6.27M Mar/2026
Eurofins Scientific SE EUR 831M 21M Dec/2025
Ionis Pharmaceuticals USD -64.53M 135.49M Mar/2026
IQVIA Holdings USD 994M 62M Jun/2026
Lonza CHF 1.01B 54M Dec/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Moderna USD -1.26B 468M Mar/2026
Organon & Co USD 371M 44M Jun/2026
Revvity USD 228.18M 44.73M Jun/2026
Tectonic Therapeutic USD -21.18M 365K Dec/2025
Viatris USD 1.19B 138.8M Jun/2026
Xeris Pharmaceuticals USD 12.33M 12.76M Mar/2026